The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

被引:0
|
作者
Peilong Lai
Xiaomei Chen
Le Qin
Zhiwu Jiang
Chenwei Luo
Xin Huang
Sujing Wu
Wei Ling
Yulian Wang
Jinghua Wang
Chenxin Deng
Lisi Huang
Lingji Zeng
Zesheng Lu
Liye Zhong
Pengjun Liao
Minming Li
Dongmei Chen
Suxia Geng
Ping Wu
Zhaoyang Tang
Duanqing Pei
Xin Du
Peng Li
Jianyu Weng
机构
[1] Guangdong Academy of Medical Sciences,Department of Hematology, Guangdong Provincial People’s Hospital
[2] University of Chinese Academy of Sciences,State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health
[3] Chinese Academy of Sciences,Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health
[4] University of Chinese Academy of Sciences,undefined
[5] Chinese Academy of Sciences,undefined
[6] Guangdong Zhaotai InVivo Biomedicine Co. Ltd,undefined
来源
Leukemia | 2020年 / 34卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2790 / 2793
页数:3
相关论文
共 50 条
  • [31] Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study
    Fu, Weijun, Sr.
    Du, Juan
    Jiang, Hua
    Cheng, Zhi
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    He, Feng
    Fang, Hongliang
    Liu, Yarong
    Wang, Pin
    BLOOD, 2019, 134
  • [32] Lymphoma immunotherapy: Efficacy, safety, and accessibility to CAR-T therapy for lymphomas
    Borchmann, Peter
    HEMASPHERE, 2018, 2 : 93 - 95
  • [33] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
  • [34] Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy
    Dolnikov, Alla
    Klamer, Guy
    Chitranjan, Arjanna
    Xu, Ning
    Shen, Sylvie
    Micklethwaite, Kenneth P.
    Lock, Richard B.
    O'Brien, Tracey
    BLOOD, 2014, 124 (21)
  • [35] IDENTIFYING THE FACTORS MODULATING THE EFFICACY OF CAR-T CELL THERAPY
    Dolnikov, A.
    Klamer, G.
    Shen, S.
    Chitranjan, A.
    Carol, H.
    Lock, R.
    O'Brien, T.
    CYTOTHERAPY, 2014, 16 (04) : S7 - S7
  • [36] Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis
    Yang, Qin
    Li, Xin
    Zhang, Fangrong
    Yang, Qiaohui
    Zhou, Wen
    Liu, Jing
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (08): : 1786 - 1797
  • [37] Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Nishimura, Noriko
    Brown, Samantha
    Sean, M. Devlin
    Parastoo, Dahi
    Heather, J. Landau
    Oscar, B. Lahoud
    Michael, Scordo
    Gunjan, L. Shah
    David, J. Chung
    Hani, Hassoun
    Malin, Hultcrantz
    Neha, Korde
    Alexander, M. Lesokhin
    Sham, Mailankody
    Urvi, A. Shah
    Carlyn, R. Tan
    Saad, Z. Usmani
    Giralt, Sergio A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1427 - S1428
  • [38] Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy
    Gu, Jingxian
    Liu, Sining
    Cui, Wei
    Dai, Haiping
    Cui, Qingya
    Yin, Jia
    Li, Zheng
    Kang, Liqing
    Qiu, Huiying
    Han, Yue
    Miao, Miao
    Chen, Suning
    Xue, Shengli
    Wang, Ying
    Jin, Zhengming
    Zhu, Xiaming
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    BLOOD, 2022, 140 : 5105 - 5107
  • [40] Efficacy and safety of BCMA-targeted CAR-T therapy in elderly patients with multiple myeloma
    Reyes, Kevin
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy
    Wolf, Jeffrey
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S5 - S5